Benzinga Pro FREE Trial︎ http://bit.ly/2Kxeaqh Benzinga Discount Codes︎ "Humbledtrader" 25% Off any plans Time stamps: 1:06 Benzinga Newsfeed (breaking news, keyword search) 3:03 Details (SEC filings research, key financial data… An examination of Zynerba Pharmaceuticals stock, its rivals, whether it's overpriced or underpriced, and a prediction for the stock in 2019. Expert advice on wills, trusts, probate and estate planning from the financial experts at MarketWatch. “We rate ZYNE Overweight. The company is developing a transdermally administered cannabidiol (CBD) gel, ZYN-002, for the treatment of behavioral symptoms associated with FXS, and seizures in developmental and epileptic encephalopathies (DEE…
Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Zynerba Pharmaceuticals Inc have a median target of 18.00, with a high estimate of
Zynerba Pharmaceuticals (ZYNE) stock price prediction is 5.497 USD. The Zynerba Pharmaceuticals stock forecast is 5.497 USD for 2021 January 13, The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique See Top Smart Score Stocks > See Stocks Similar to ZYNE ➞. Jun 11, 2019 Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) is up more than 12% in mid-day trading today after announcing news with regard to a Click to see Stock Price Quote detail and other financial information on ZYNE, or here to see Zynerba Pharmaceuticals Inc Dividend Stock News and Updates. Did cover my #ZYNE swing short position from last week for a -2K paper cut cus VOLUME AND GREAT DEA NEWS AS WELL #CBD NOW SCHEDULE "V". #ZYNE Zynerba Pharmaceuticals -4.45% See more top #cannabis #stocks today! Jan 8, Easy Come, Easy Go: How Zynerba Pharmaceuticals (NASDAQ:ZYNE) Shareholders Got Unlucky And Saw
Exploring Zynerba Pharmaceuticals (NASDAQ:ZYNE) stock? View ZYNE's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.
10/01/2020 · View today's stock price, news and analysis for Zynerba Pharmaceuticals Inc. (ZYNE). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. 03/01/2020 · Zynerba Pharmaceuticals, Inc. (ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced the publication of data from the Phase 2 FAB-C clinical trial. This new publication can be accessed at the following link: https://rdcu.be/bMTnd. ZYNE stock has jumped almost 45% since the FDA’s news. ZYNE Stock gets $36 PT from Roth Capital. On April. 30, Jerry Isaacson, an analyst at Roth Capital, started coverage on ZYNE’s stock and set a price target of $36, a potential jump of 125% from the current market price. ZYNE is a long term investment stock, itll continue fluctuating; you just need the patience until they get the treatment FDA approved and commercially distributed, thats when the real money will be made. 18/08/2019 · Looking for insights on Zynerba-pharmaceuticals (NASDAQ:ZYNE) stock? View ZYNE's stock ratings, price targets, earnings, commentary and news at Smarter Analyst.
5 days ago The 51 rating InvestorsObserver gives to Zynerba Pharmaceuticals Inc (ZYNE) stock puts it near the top of the Biotechnology industry.
Find high-quality Keulen stock photos and editorial news pictures from Getty Images. Download premium images you can't get anywhere else.
Zynerba Pharmaceuticals stock quote and ZYNE charts. Latest stock price today and the US's most active stock market forums.
Learn about ZYNE with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on ZYNE. 10/01/2020 · ZYNE Zynerba Pharmaceuticals, Inc. Common Stock (ZYNE) Earnings Report Date. Zynerba Pharmaceuticals, Inc. Common Stock (ZYNE) Earnings Report Date. Earnings announcement* for ZYNE: New to earnings? Here's a quick guide for how to read an earnings report. Visit the Earnings Calendar to see dates for upcoming earnings announcements. Latest Reports. Stock: Title % of value: Value per share: 2020-01-12 (zyne) Zyne : 27c - the optimal room temperature for a babies room View the latest ZYNE stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ZYNERBA PHARMACEUTICALS, INC.. Get Zynerba Pharmaceuticals Inc (ZYNE:NASDAQ) real-time stock quotes, news and financial information from CNBC. News. The latest news about cannabis companies, investments, legalization, and more. The best-in-industry source for cannabis stock data. Cannabis IPO Hotlist. NICI’s exclusive list of all coming IPOs. ZYNE Options Prices Calls (Expiration: 01/10/2020) Contract … Zynerba Pharmaceuticals stock quote and ZYNE charts. Latest stock price today and the US's most active stock market forums.
Biggest stock gainers — USA. See the most notable stocks on the market.